Related Experiment Video
Updated: Jul 13, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Cellular and molecular mechanisms for rapid regression of atherosclerosis: from bench top to potentially achievable
Kevin Jon Williams1, Jonathan E Feig, Edward A Fisher
1Department of Medicine/Division of Endocrinology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Purpose Of Review:
Decades of literature have unambiguously demonstrated regression and remodeling of atherosclerotic lesions, including advanced plaques. Recent insights into underlying mechanisms are reviewed.
Recent Findings:
Factors promoting regression include decreased apolipoprotein B-lipoprotein retention within the arterial wall, efflux of cholesterol and other harmful lipids from plaques, and emigration of lesional foam cells followed by entry of healthy phagocytes that remove necrotic debris and other plaque components. Cellular lipid efflux and foam cell emigration can occur surprisingly rapidly once the plaque milieu is improved. Lipid efflux and foam cell emigration each involve specific molecular mediators, many of which have been identified. Necrotic debris removal can be surprisingly comprehensive, with essentially full disappearance documented in animal models.
Summary:
The essential prerequisite for regression is robust improvement in plaque milieu, meaning large plasma reductions in atherogenic apolipoprotein B-lipoproteins or brisk enhancements in 'reverse' lipid transport from plaque into liver. Importantly, the processes of regression are consistent with rapid correction of features characteristic of the rupture-prone, vulnerable plaques responsible for acute coronary syndromes. New interventions to lower apolipoprotein B-lipoprotein levels and enhance reverse lipid transport may allow regression to become a widespread clinical goal. Strategies based on recent mechanistic insights may facilitate further therapeutic progress.
Insights
Atherosclerotic plaque regression is possible through improved arterial health, leading to reduced plaque buildup and better outcomes for vulnerable plaques. Enhanced lipid transport and reduced lipoprotein retention are key factors.
Area of Science:
- Cardiovascular Research
- Atherosclerosis Pathophysiology
- Molecular Medicine
Background:
- Decades of research confirm that atherosclerotic lesions, including advanced plaques, can undergo regression and remodeling.
- Recent scientific advancements have elucidated the underlying mechanisms driving plaque regression.
Purpose of the Study:
- To review recent insights into the mechanisms of atherosclerotic plaque regression and remodeling.
- To highlight factors promoting plaque regression and their clinical implications.
Main Methods:
- Review of existing literature on atherosclerotic lesion regression.
- Analysis of molecular and cellular mechanisms involved in plaque regression.
- Synthesis of findings related to lipid metabolism and cellular transport in atherosclerosis.
Main Results:
- Plaque regression is promoted by reduced arterial retention of apolipoprotein B-lipoproteins and enhanced cholesterol efflux.
- Foam cell emigration and subsequent removal of necrotic debris by phagocytes contribute significantly to plaque regression.
- Cellular lipid efflux and foam cell emigration can be rapid following improvements in the plaque environment.
Conclusions:
- Atherosclerotic plaque regression requires significant improvement in the plaque milieu, primarily through reduced atherogenic lipoproteins or enhanced reverse lipid transport.
- Regression processes can rapidly correct features of vulnerable plaques associated with acute coronary syndromes.
- New therapeutic strategies targeting lipoprotein levels and reverse lipid transport could establish plaque regression as a clinical objective.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Inflammation
Pharmacogenomics: Identification of New Drug Targets
Coronary Artery Disease I: Introduction
